Multiple endocrine neoplasia (MEN) II
Multiple endocrine neoplasia, type II (MEN II) is an inherited disorder in which one or more of the endocrine glands are overactive or form a tumor. Endocrine glands most commonly involved include:
- Adrenal (about half the time)
- Parathyroid (20% of the time)
- Thyroid (almost all of the time)
See also: MEN I
Sipple syndrome; MEN II
The cause of MEN II is a defect in a gene called RET. This defect causes many tumors to appear in the same person, but not necessarily at the same time. The adrenal tumor is called a pheochromocytoma, and the thyroid tumor is a medullary carcinoma of the thyroid.
The tumors involve multiple parts of the thyroid gland or more than one of the parathyroid and adrenal glands. Tumors in the thyroid, adrenal, or parathyroid glands may occur years apart.
The disorder may occur at any age, and affects men and women equally. The main risk factor is a family history of MEN II.
There are two subtypes of MEN II -- MEN IIa and IIb. MEN IIb is less common.
The symptoms may vary. However, they are similar to those of:
Exams and Tests
To diagnose this condition, the health care provider looks for a mutation in the RET gene. This can be done with a blood test. Additional tests are done to determine which hormones are being overproduced.
A physical examination may reveal:
Imaging tests used to identify tumors may include:
- Abdominal CT scan
- Imaging of the kidneys or ureters
- MIBG scintiscan
- MRI of abdomen
- Radioimmune assay of parathyroid hormone
- Thyroid scan
- Ultrasound of the thyroid
Blood tests are used to evaluate the function of each endocrine gland. The following tests may be performed:
- Calcitonin level
- Blood alkaline phosphatase
- Blood calcium
- Blood phosphorus
- Urine catecholamines
- Urine metanephrine
Other tests or procedures that may be done include:
Surgery is needed to remove pheochromocytoma.
For medullary carcinoma of the thyroid, the thyroid gland and surrounding lymph nodes must be totally removed. Thyroid hormone replacement therapy is given after surgery.
If a child is known to carry the RET gene mutation, surgery to remove the thyroid before it becomes cancerous is considered. This should be discussed with a physician who is very familiar with this condition. It would be done at an early age (before age 5) in people with known MEN IIa, and before age 6 months in people with MEN IIb.
Pheochromocytoma is usually not cancerous (benign). Medullary carcinoma of the thyroid is a very aggressive and potentially fatal cancer. However, early diagnosis and surgery can often lead to a cure.
The spread of cancerous cells is a possible complication.
When to Contact a Medical Professional
Call your health care provider if you notice symptoms of MEN II or if someone in your family receives such a diagnosis.
Screening close relatives of people with MEN II may lead to early detection of the syndrome and related cancers.
Kronenberg HM. Plyglandular disorders. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 250.
National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Neuroendocrine Tumors. National Comprehensive Cancer Network; 2009. Version 2.2009.
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.